Arteris (AIP) Q1 2026 earnings review
Top-Line Acceleration Masks Near-Term Cash Burn
Arteris delivered a blistering 39% YoY revenue surge in Q1, driven by relentless demand for AI-enabled chips and complex chiplet architectures. Forward-looking metrics are just as strong: Remaining Performance Obligation (RPO) jumped 33% and ACV plus royalties hit a record $92.8 million. However, the aggressive growth strategy and the recent Cycuity acquisition have temporarily reversed cash flow, turning a recent streak of positive FCF into a $7.4 million burn this quarter. While non-GAAP operating losses are narrowing, GAAP losses actually widened due to acquisition costs. Arteris is successfully capturing the AI hardware boom, but investors must tolerate messy near-term financials as the company digests its recent M&A.
🐂 Bull Case
RPO grew 33% to $118.3M, and top-line revenue growth accelerated to 39% YoY. Arteris is rapidly becoming a default interconnect standard for hyperscalers and automotive OEMs navigating the shift to multi-die systems.
Trailing-twelve-months variable royalties grew 67% YoY. As legacy design wins enter volume production, this high-margin recurring revenue stream is structurally lifting the company's baseline profitability.
🐻 Bear Case
Despite 39% revenue growth, GAAP operating losses widened from $7.7M to $9.3M, and Free Cash Flow swung to a negative $7.4M as Cycuity acquisition costs and integration fees bit into the balance sheet.
The retirement of CFO Nick Hawkins in August 2026 introduces execution risk during a critical window when the company is attempting to cross the threshold into sustained non-GAAP profitability.
⚖️ Verdict: 🟢
Bullish. The widening GAAP loss and FCF burn are clear concerns, but they are largely tied to the strategic Cycuity acquisition. The underlying fundamental metrics—39% revenue growth, 33% RPO growth, and 67% royalty growth—prove the core IP model is highly leveraged to the multi-year AI supercycle.
Key Themes
AI & Chiplet Architectures Propelling ACV
Accelerating. The industry's rapid pivot to chiplet architectures and AI accelerators continues to be Arteris's primary engine. A leading global hyperscaler expanded its technology use, and a global memory supplier chose Arteris to accelerate High Bandwidth Memory (HBM) chip development. This directly drove the 39% YoY surge in ACV plus royalties, establishing a durable revenue pipeline.
Cycuity Cross-Sell Taking Shape
Accelerating. The integration of Cycuity's cybersecurity IP is already yielding results. A leading U.S.-based hyperscaler (an existing interconnect customer) licensed Arteris security technology this quarter to mitigate cybersecurity risks. This validates management's prior claim that cybersecurity IP can serve as a highly effective cross-sell mechanism to raise average project selling prices.
Variable Royalty Stream Scaling Rapidly
Accelerating. Trailing-twelve-months variable royalties hit $7.9 million, up 67% YoY. While a smaller absolute dollar figure compared to licensing, royalties carry essentially zero marginal cost. This growth indicates that the massive volume of design wins accumulated over the past 3-5 years is finally beginning to cross over into commercial manufacturing volumes.
Cash Flow Reversal from M&A Action
Reversing. After posting positive Free Cash Flow of $3.0 million in 25Q4, FCF swung dramatically to a negative $7.4 million in 26Q1. This was largely driven by a $11.2 million net cash outflow for the Cycuity business combination and related integration costs. While Q2 guidance expects a return to positive FCF, this sharp quarter-over-quarter burn highlights the capital intensity of the company's M&A strategy.
GAAP Profitability Diverging from Narrative
Stable but problematic. Management consistently highlights progress toward non-GAAP profitability, but actual GAAP metrics tell a conflicting story. Despite the massive 39% revenue beat, GAAP operating loss actually worsened from $7.7M a year ago to $9.3M today. This margin compression was driven by $5.5M in stock-based compensation (up 27% YoY) and $0.6M in direct acquisition costs. Investors relying purely on the adjusted numbers are missing the true cost of operations.
Executive Transition Risk
New. CFO Nick Hawkins is retiring effective August 31, 2026. While he led the company through its IPO and the recent Cycuity acquisition, changing a core executive while attempting to achieve sustained profitability and integrate a major acquisition introduces significant execution risk.
Macro and Geopolitical Headwinds
Stable. Management's forward-looking statements continue to explicitly warn of macro-economic conditions including the imposition of tariffs and geopolitical conflicts (Middle East, Russia/Ukraine, US/China relations). Given Arteris's reliance on global automotive and consumer electronics supply chains for royalty generation, these macro factors remain a constant background threat to the otherwise stellar growth.
Other KPIs
Accelerating. Up 26% from $15.3 million in Q1 2025. This forms the bedrock of the company's revenue and proves that the aggressive R&D investments in products like FlexGen and Ncore are translating directly into signed, billable contracts.
Accelerating. Up 33% YoY from Q1 2025, and up slightly sequentially from $117.0M in Q4 2025. This metric effectively guarantees revenue visibility for the next 12-24 months and heavily de-risks the company's aggressive full-year guidance.
Guidance
Accelerating YoY, Stable QoQ. The $23.5M midpoint implies a 42% YoY surge compared to the $16.5M reported in Q2 2025. Sequentially, it reflects stable, sustained momentum following Q1's strong $22.9M print.
Reversing. The midpoint of $5.0M implies a rapid recovery from Q1's $7.4M burn, suggesting the cash drain was heavily isolated to one-time M&A payments rather than structural operational decay.
Accelerating. The $93.0M midpoint represents approximately 32% growth over FY25's $70.6M. This aggressive full-year target is well-supported by the current $118.3M RPO backlog.
Stable to improving. Represents significant year-over-year leverage compared to the $12.5M non-GAAP loss recorded in FY25. The company is slowly marching toward breakeven on an adjusted basis, though GAAP profitability remains distant.
Key Questions
Cycuity Integration and Margin Drag
The Q1 non-GAAP operating loss was $2.5M, but GAAP was $9.3M. How quickly will the one-time integration fees related to Cycuity burn off, and what is the normalized run-rate for stock-based compensation post-acquisition?
CFO Transition Strategy
With Nick Hawkins retiring in August 2026 just as the company is guiding toward non-GAAP profitability, what specific traits are you looking for in a successor to manage this critical financial inflection point?
HBM and Hyperscaler Royalty Dynamics
You announced new wins with a hyperscaler and an HBM memory supplier. Given the massive volumes associated with AI data centers, do these specific segments carry higher or lower variable royalty rates compared to your legacy automotive base?